The Enterprise Value as of December 2024 (TTM) for Defence Therapeutics Inc. (DTCFF) is 29.96M

According to Defence Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 29.96M. This represents a change of -50.39% compared to the average of 60.40M of the last 4 quarters.

Defence Therapeutics Inc. (DTCFF) Historical Enterprise Value (quarterly & annually)

How has DTCFF Enterprise Value performed in the past?

The mean historical Enterprise Value of Defence Therapeutics Inc. over the last ten years is 98.13M. The current 29.96M Enterprise Value has changed 2.95% with respect to the historical average. Over the past ten years (40 quarters), DTCFF's Enterprise Value was at its highest in in the June 2021 quarter at 242.85M. The Enterprise Value was at its lowest in in the December 2019 quarter at 0.

Defence Therapeutics Inc. (DTCFF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Defence Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Defence Therapeutics Inc. (DTCFF) Average Enterprise Value

How has DTCFF Enterprise Value performed in the past?

The current Enterprise Value of Defence Therapeutics Inc. (DTCFF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Defence Therapeutics Inc. (DTCFF) Enterprise Value vs. Peers

How is DTCFF’s Enterprise Value compared to its peers?

Defence Therapeutics Inc.’s Enterprise Value is less than Sino Biopharmaceutical Limited (56.95B), less than Institute of Biomedical Research Corp. (41.31M), greater than Aileron Therapeutics, Inc. (29.36M), greater than Enlivex Therapeutics Ltd. (25.04M), greater than Panbela Therapeutics, Inc. (7.92M), greater than Lixte Biotechnology Holdings, Inc. (3.06M), less than Benitec Biopharma Inc. (201.22M), greater than Cingulate Inc. (5.81M), greater than TRACON Pharmaceuticals, Inc. (-6160275.00), less than XOMA Corporation (296.56M), less than Fortress Biotech, Inc. (62.64M), less than Checkpoint Therapeutics, Inc. (170.50M), less than ZIVO Bioscience, Inc. (78.24M), greater than Lumos Pharma, Inc. (24.19M), less than Apellis Pharmaceuticals, Inc. (0), less than Terns Pharmaceuticals, Inc. (4.22B), less than Day One Biopharmaceuticals, Inc. (223.81M), less than Blueprint Medicines Corporation (857.57M), less than Cerevel Therapeutics Holdings, Inc. (6.13B), less than null (8.24B),

Build a custom stock screener for Defence Therapeutics Inc. (DTCFF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Defence Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Defence Therapeutics Inc. (DTCFF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Defence Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.